The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ

被引:1
|
作者
Na, Jinrui [1 ,2 ]
Engwerda, Christian [1 ]
机构
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
关键词
visceral leishmaniasis; immunoregulation; CD4(+) T cell; Nkg7 and TGF beta; IL-10; GROWTH-FACTOR-BETA; AZAR DERMAL LEISHMANIASIS; TUMOR-NECROSIS-FACTOR; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; IFN-GAMMA; DISTINCT ROLES; EXTRACELLULAR-MATRIX; BINDING-PROTEINS; MESSENGER-RNA;
D O I
10.3389/fcimb.2024.1414493
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Visceral leishmaniasis is a potentially devastating neglected tropical disease caused by the protozoan parasites Leishmania donovani and L. infantum (chagasi). These parasites reside in tissue macrophages and survive by deploying a number of mechanisms aimed at subverting the host immune response. CD4(+) T cells play an important role in controlling Leishmania parasites by providing help in the form of pro-inflammatory cytokines to activate microbiocidal pathways in infected macrophages. However, because these cytokines can also cause tissue damage if over-produced, regulatory immune responses develop, and the balance between pro-inflammatory and regulatory CD4(+) T cells responses determines the outcomes of infection. Past studies have identified important roles for pro-inflammatory cytokines such as IFN gamma and TNF, as well as regulatory co-inhibitory receptors and the potent anti-inflammatory cytokine IL-10. More recently, other immunoregulatory molecules have been identified that play important roles in CD4+ T cell responses during VL. In this review, we will discuss recent findings about two of these molecules; the NK cell granule protein Nkg7 and the anti-inflammatory cytokine TGF beta, and describe how they impact CD4+ T cell functions and immune responses during visceral leishmaniasis.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] THE ROLE OF CD4+ T-CELLS IN RAT CRYPTOCOCCOSIS
    ARSIC, V
    KRANJCICZEC, I
    MITROVIC, S
    RAMIC, Z
    MOSTARICASTOJKOVIC, M
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 422 - 423
  • [32] A novel role for CD4+ T cells in the control of cachexial
    Wang, Zhuangzhi
    Zhao, Chunfang
    Moya, Rosa
    Davies, Joanna D.
    JOURNAL OF IMMUNOLOGY, 2008, 181 (07): : 4676 - 4684
  • [33] Paradigm Shifts in the Role of CD4+ T Cells in Keratoplasty
    Cunnusamy, Khrishen
    Chen, Peter W.
    Niederkorn, Jerry Y.
    DISCOVERY MEDICINE, 2010, 10 (54) : 452 - 461
  • [34] The Role of CD4+ T Cells and Microbiota in the Pathogenesis of Asthma
    Jeong, Jiung
    Lee, Heung Kyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [35] A Dual Role of CD4+ T Cells in Adipose Tissue?
    Matter, Christian M.
    Stein, M. A. Sokrates
    CIRCULATION RESEARCH, 2009, 104 (08) : 928 - 930
  • [36] The Role of Notch in the Differentiation of CD4+ T Helper Cells
    Auderset, Floriane
    Coutaz, Manuel
    Tacchini-Cottier, Fabienne
    NOTCH REGULATION OF THE IMMUNE SYSTEM, 2012, 360 : 115 - 134
  • [37] Cross-talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis:: CD8+ T cells are required for optimal IFN-γ production by CD4+ T cells
    Herath, S
    Kropf, P
    Müller, I
    PARASITE IMMUNOLOGY, 2003, 25 (11-12) : 559 - 567
  • [38] TYPE I INTERFERONS SUPPRESSES ANTI-PARASITIC CD4+ T CELL RESPONSES IN VISCERAL LEISHMANIASIS
    Kumar, Rajiv
    Bunn, Patrick
    Rivera, Fabian
    Singh, Neetu
    Sundar, Shyam
    Engwerda, Christian
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 646 - 646
  • [39] Distinct roles of dendritic and B cells in the activation of naive CD4+ T cells
    Rudulier, Chritopher D.
    Kroeger, David R.
    Bretscher, Peter A.
    IMMUNOTHERAPY, 2012, 4 (04) : 355 - 357
  • [40] CD4+T cells show a cytolytic phenotype functions in human visceral leishmaniasis
    Singh, Om Prakash
    Chauhan, Shashi Bhushan
    Singh, Siddharth Sankar
    Engwerda, Christian
    Kumar, Rajiv
    Sundar, Shyam
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):